Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial.
BMJ Open. 2018 Apr 26;8(4):e021876
Cancer Causes Control. 2018 Apr 20;:
Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2018 Feb 05;:
Breast Cancer Res Treat. 2017 Nov 24;:
Results of a phase II study of single-agent nab-paclitaxel in platinum-refractory second-line metastatic urothelial carcinoma (UC).
J Clin Oncol. 2011 Mar;29(7_suppl):241
Phase II study of MKC-1 in patients with metastatic or resistant epithelial ovarian cancer or advanced endometrial cancer.
J Clin Oncol. 2009 May 20;27(15_suppl):5577
Genome-Wide DNA Methylation Analysis Reveals Epigenetic Dysregulation of MicroRNA-34A in TP53-Associated Cancer Susceptibility.
J Clin Oncol. 2016 Aug 22;
Clin Genet. 2015 Jul 29;
Eur J Surg Oncol. 2015 Feb 7;
Blood levels of vitamin D and early stage breast cancer prognosis: a systematic review and meta-analysis.
Breast Cancer Res Treat. 2013 Oct;141(3):331-9